Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Rossignol

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Autoimmunity Reviews|December 16, 2019
Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature reviewAnne Laure Roupie, Hubert de Boysson, Sara Thietart, et al.
Blood Cancer Journal|November 5, 2025
Telomere occupancy by TRF2 is altered by KIT mutations and correlates with mastocytosis regressionJulie Bruneau, Sophie Georgin-Lavialle, Sophia Ladraa, et al.
Journal of Clinical Medicine|December 10, 2021
USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly PatientsMarion Delplanque, Achille Aouba, Pierre Hirsch, et al.
British Journal of Haematology|February 17, 2023
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective studySammara Chaubard, Amira Marouf, David Lavergne, et al.
JAMA Dermatology|May 28, 2025
Characteristics and Therapeutic Strategies for Diffuse Cutaneous MastocytosisPaula Pernea, Cecile Méni, Julien Rossignol, et al.
Haematologica|October 15, 2020
XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemiaFlavia Guillem, Michaël Dussiot, Elia Colin, et al.
Autoimmunity Reviews|July 15, 2017
Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patientsArsene Mekinian, Guillaume Dervin, Nathanael Lapidus, et al.
Blood|September 19, 2025
VEXAS anemia is a mosaic erythroblastopeniaFrancois Rodrigues, Giulia Hardouin, Sara El Hoss, et al.
The Journal of Allergy and Clinical Immunology|August 16, 2024
Interactions between eosinophils and IL-5Rα-positive mast cells in nonadvanced systemic mastocytosisGuillaume Lefèvre, Jean-Baptiste Gibier, Antonino Bongiovanni, et al.
Orphanet Journal of Rare Diseases|April 30, 2023
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromesMatthieu Groh, Julien Rohmer, Nicolas Etienne, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Autoimmunity Reviews|December 16, 2019
Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature reviewAnne Laure Roupie, Hubert de Boysson, Sara Thietart, et al.
Blood Cancer Journal|November 5, 2025
Telomere occupancy by TRF2 is altered by KIT mutations and correlates with mastocytosis regressionJulie Bruneau, Sophie Georgin-Lavialle, Sophia Ladraa, et al.
Journal of Clinical Medicine|December 10, 2021
USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly PatientsMarion Delplanque, Achille Aouba, Pierre Hirsch, et al.
British Journal of Haematology|February 17, 2023
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective studySammara Chaubard, Amira Marouf, David Lavergne, et al.
JAMA Dermatology|May 28, 2025
Characteristics and Therapeutic Strategies for Diffuse Cutaneous MastocytosisPaula Pernea, Cecile Méni, Julien Rossignol, et al.
Haematologica|October 15, 2020
XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemiaFlavia Guillem, Michaël Dussiot, Elia Colin, et al.
Autoimmunity Reviews|July 15, 2017
Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patientsArsene Mekinian, Guillaume Dervin, Nathanael Lapidus, et al.
Blood|September 19, 2025
VEXAS anemia is a mosaic erythroblastopeniaFrancois Rodrigues, Giulia Hardouin, Sara El Hoss, et al.
The Journal of Allergy and Clinical Immunology|August 16, 2024
Interactions between eosinophils and IL-5Rα-positive mast cells in nonadvanced systemic mastocytosisGuillaume Lefèvre, Jean-Baptiste Gibier, Antonino Bongiovanni, et al.
Orphanet Journal of Rare Diseases|April 30, 2023
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromesMatthieu Groh, Julien Rohmer, Nicolas Etienne, et al.
Pageof 14